<DOC>
	<DOCNO>NCT01724203</DOCNO>
	<brief_summary>The purpose clinical trial evaluate safety effectiveness 12-week probiotic supplementation incidence duration infectious episode infant age 6 12 month .</brief_summary>
	<brief_title>Effect 12-week Probiotic Supplementation Bacterial Viral Infections Infants Aged 6 12 Months .</brief_title>
	<detailed_description>Probiotics live bacteria offer health benefit host administer via diet adequate amount . Probiotic supplementation safe use infant elderly demonstrate beneficial effect wide variety health condition acute diarrhea , antibiotic-associated diarrhea , allergy , inflammatory bowel disease . The immune-enhancing benefit probiotic attractive , particularly infant , group particularly prone variety infection , e.g . respiratory tract infection , strep throat , diarrhea . Probiotic supplementation utilize previous study childhood infection promise result . In study , safety effectiveness 12-week probiotic supplementation incidence duration infectious episode infant age 6 12 month determine . The subject receive follow-on formula contain 1 million CFU/g Lactobacillus rhamnosus HN001 ( trademark DR20 ) , 1 million CFU/g Bifidobacterium animalis subsp . lactis HN019 ( trademark DR10 ) , placebo formula least three feed per day 12 week .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<criteria>Age 6 12 month . Known vaccination history . Ability participant 's parent legal guardian comprehend full nature purpose study include possible risk side effect . Parental legal guardian 's consent study willing comply study procedure . Symptoms infection screen . History â‰¥5 infection previous 2 month . Lactose intolerance unable drink milk . Leukopenia leukocytosis . Immunodeficient use immunosuppressive drug . Use antibiotic antiinflammatory medication within last 2 week . Use product contain prebiotics probiotic within last 2 week . Use lowlactose lactosefree infant followon formula within last 2 week . Hepatitis B C. Medications supplement may affect subject safety confound study outcomes opinion investigator . Medical condition disease may affect subject safety confound study result opinion investigator . Participation another study investigational product within 3 month screen . Any condition , investigator 's opinion , may preclude subject 's ability safely complete trial .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>12 Months</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Probiotics infant</keyword>
	<keyword>Bacterial viral infection infant</keyword>
</DOC>